Bon Health review
Four term lengths are published for each molecule, and the coverage list runs to every state.
The verdict
Bon Health publishes $220 a month for semaglutide and $285 for tirzepatide without a commitment, across 50 states. Four term lengths are published beside them, which is more structure than most compounded sellers publish.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 50
- From
- From $220/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- All 50 states
Bon Health sells compounded semaglutide and compounded tirzepatide by injection. Tirzepatide costs more at every term. Coverage is recorded in all fifty states.
Who writes the prescription, and what do they see?
A prescription is issued before shipping and the pages name terms rather than clinicians. The intake is not described anywhere on the site. The pricing structure is documented in detail; the clinical one is not documented at all.
Remote, with the commitment length as the main variable a buyer chooses. Four terms are offered, and the monthly figure falls as the term lengthens.
What happens when the dose goes up?
Nothing is published about what the figure does at a higher dose, and the term structure makes that gap matter more. A buyer choosing the longest term fixes a commitment across an escalation whose cost behavior is unstated.
What the price includes
Month to month, semaglutide is $220 and tirzepatide $285. Six months at those rates is $1,320 and $1,710. The annual plan is billed once, at $1,140 and $1,620, which is $95 and $135 a month.
What it claims, and what it cites
Both lines are compounded, not manufactured. A pharmacy prepares them and the FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: Coverage recorded in all fifty states
- Strength: Every rung priced for both molecules
- Strength: Four term lengths published, not one
- Limitation: The lower figures require longer locks
- Limitation: No dose behavior published anywhere
- Limitation: No compounding pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about Bon Health. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A buyer in a state few sellers reach who wants every commitment length priced up front.
- Wrong for
- A buyer unwilling to trade term length for a lower monthly figure.
The evidence behind what Bon Health prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Bon Health compares
| Seller | Who it suits | Go |
|---|---|---|
 Citizen Meds | Readers who want the escalation named up front rather than discovered on a statement | See Citizen Meds → |
 Coivas | Readers comparing headline figures who will ask about dose and coverage before ordering | See Coivas → |
 Avono Health | Buyers who expect to titrate and want one monthly price at every dose | See Avono Health → |
More GLP-1 telehealth sellers reviews: SexyMDShapeIn RxShapelySignosSilhouette MDSkyRx
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is tirzepatide more expensive here?
- Yes. Month to month it is $285 against $220 for semaglutide, a $65 step.
- How do the four terms differ?
- The monthly figure falls as the term lengthens. The trade is a longer commitment for a lower rate, and the structure is published rather than hidden.
- Where does Bon Health ship?
- All fifty states are recorded in its coverage list.
- Is Bon Health legit?
- Bon Health is a GLP-1 telehealth sellers service. Its stated availability: All 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is Bon Health expensive compared with other GLP-1 telehealth sellers?
- Bon Health publishes a starting figure of $220/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Bon Health above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.